2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

PHASE2CompletedINTERVENTIONAL
Enrollment

1,368

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

January 31, 2023

Study Completion Date

December 31, 2024

Conditions
Latent Tuberculosis
Interventions
DRUG

Rifampin double dose

Double dose of rifampin for 2 months.

DRUG

Rifampin triple dose

Triple dose of rifampin for 2 months.

DRUG

Rifampin standard dose

Standard dose of rifampin for 4 months.

Trial Locations (9)

Unknown

Unviversity of Calgary, Calgary

BCCDC TB clinic, Vancouver

Universitas Padjadjaran, Klinik Penelitian Tuberculosis (TB research clinic), Bandung

Hai Ba Trung District Health Center, No. 16B, Hà Nội

Hanoi Lung Hospital, Hà Nội

Nam Tu Liem District Health Center, No. 3, Hà Nội

Phoi Viet TB and Respiratory Diseases Clinic., Ho Chi Minh City

T6G 2C8

The Governors of the University of Alberta, Edmonton

H4A 3J1

MUHC, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT03988933 - 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. | Biotech Hunter | Biotech Hunter